Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

HSDT - Helius Medical Technologies Inc - Ordinary Shares - Class A


IEX Last Trade
0.764
-0.036   -4.725%

Share volume: 48,188
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$0.80
-0.04
-4.51%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
29%
Profitability 33%
Dept financing 19%
Liquidity 38%
Performance 25%
Company vs Stock growth
vs
Performance
5 Days
4.66%
1 Month
5.38%
3 Months
-47.67%
6 Months
-82.71%
1 Year
-90.37%
2 Year
-97.27%
Key data
Stock price
$0.76
P/E Ratio 
-0.31
DAY RANGE
N/A - N/A
EPS 
-$7.62
52 WEEK RANGE
$0.65 - $13.43
52 WEEK CHANGE
-$0.90
MARKET CAP 
2.732 M
YIELD 
N/A
SHARES OUTSTANDING 
3.576 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/11/2024
BETA 
0.20
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$59,936
AVERAGE 30 VOLUME 
$52,205
Company detail
CEO: Philippe Deschamps
Region: US
Website: http://www.heliusmedical.com/
Employees: 34
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

helius medical technologies, inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. the company's product is portable neuromodulation stimulator (pons), a medical device in canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. its pons device treats neurostimulation of cranial nerves via the tongue to restore lost function. the company is headquartered in newtown, pennsylvania.

Recent news